Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer
about
Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin bindingDAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor statusPlacental expression of estrogen receptor beta and its hormone binding variant--comparison with estrogen receptor alpha and a role for estrogen receptors in asymmetric division and differentiation of estrogen-dependent cellsMolecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast CarcinogenesisHuman mammaglobin in breast cancer: a brief review of its clinical utilityThe role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβERbeta in breast cancer--onlooker, passive player, or active protector?Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsiesThe expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.mRNA expression of steroidogenic enzymes, steroid hormone receptors and their coregulators in gastric cancer.Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation.Estrogen receptors and proliferation markers in primary and recurrent breast cancerEstradiol increases ER-negative breast cancer metastasis in an experimental model.Estrogen receptor beta in prostate cancer: brake pedal or accelerator?ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerParacrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary glandPreliminary study of quercetin affecting the hypothalamic-pituitary-gonadal axis on rat endometriosis model.Expression and prognostic value of estrogen receptor beta in breast cancer patients.Predictive and prognostic markers for invasive breast cancer.Oestrogen receptor beta in breast cancer: good, bad or still too early to tell?Expression of Estrogen Sulfotransferase 1E1 and Steroid Sulfatase in Breast Cancer: A Immunohistochemical StudyThe potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer.Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancerEndocrine-responsive breast cancer and strategies for combating resistance.Molecular action of the estrogen receptor and hormone dependency in breast cancer.ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer.The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer.New insights into estrogen receptor function in human breast cancer.Role of estrogen receptor signaling in breast cancer metastasis.Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer.Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters.Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter.Loss of ERbeta expression as a common step in estrogen-dependent tumor progressionEstrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesisEstrogen receptor-beta and breast cancer: translating biology into clinical practicePrognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer.ER beta inhibits proliferation and invasion of breast cancer cellsExpression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumors: implications for targeted therapyERβ expression and breast cancer risk prediction for women with atypias.
P2860
Q24647300-12C3B864-9EC7-467F-BBE5-2B10599F4D3DQ24794574-B33B6B04-D13F-4579-9F1A-F5C75631B31BQ24797494-2C060C05-A8E3-4545-A68D-59A484F797F7Q26744296-8BFA9FD3-D375-420C-9794-863DBF474990Q27001274-7B030A92-116A-414F-B502-5519E3888B1CQ28390036-77C18294-AD67-40EE-84BD-347A44925C32Q28480546-E2496315-98CE-4343-876C-56BE45E7656EQ30438399-246A6F2C-AE28-43B0-A482-97955D7AB703Q31040434-B02BADEE-C9E8-4213-9793-BACFD0BD0D11Q33421063-5A7F7CB1-32DA-40D2-8AC6-56AE6663CFDEQ33684994-EC032D14-8336-44AE-B8DC-DF8A071FDFC4Q33944679-5AF559D5-4E41-44B9-8116-266A93BC6B03Q33953032-DE239F90-0A10-44EF-9435-9552261D084AQ34118227-6E1342CD-D00C-4470-A4A0-23E76D65B681Q34299700-0847505D-E644-403B-AEBB-5635723DED84Q34334131-1C99BD70-F06A-4009-9864-2AD873FD72E2Q34479251-AD413416-FE04-4552-BA59-565862872F1CQ34495897-876353F8-106E-465E-A393-D673F4590A97Q34547653-7B68A14A-C3AE-42AA-87F9-A60C94ADCC90Q34612314-2A4D8751-A628-45D6-998C-C2F2112DF32AQ34642084-B228262D-2199-42A9-8E87-5402F6D5EF8DQ34908906-950B430D-625E-48B6-8281-0828FF1AB021Q34982010-CBBC37EE-CF97-492E-959A-62BB8160AA8DQ34991926-FE2990A9-77BC-4F16-972F-C5B1DD810F89Q35084786-88FB4D69-38CA-4204-A6AE-F847F3C3B612Q35123562-B080B0D2-6516-4981-BCD9-2FACD4CBAF0DQ35168154-A0A5DF48-E85C-44EB-9DA1-6A613184C1A6Q35587582-4DEB3FC8-666A-4225-892E-FCDE5B0B4707Q35622050-D2D66A11-8305-4CD8-9E82-74967CB90328Q35684545-287C98F2-E53D-4647-BC4B-03DE969AB3A3Q35758100-8F672E75-CA4A-4824-A5E5-A8E1BF5CB798Q35786187-B920FA79-A615-46D5-97FE-57D2C60B1FB2Q35794268-C9B7711D-7422-4B7D-9B73-B2F992061DA1Q35888377-C153FCC2-AA60-4DB1-A107-362CC5C96FC9Q35929364-E5A848FB-58A3-4287-939A-B5C4972078FDQ35973424-D5084BFC-1D48-41D8-8531-5ADADE1C0CF1Q35993074-F19F2979-83AD-472C-A7D1-C742A871E308Q36089436-B0A54213-695A-4BF3-8A27-1163E16D8DC3Q36236672-3A5BC66A-4FE0-40A4-848B-7C84227F0575Q36248899-B7806400-69AC-495C-9BC6-37434A4DAFAF
P2860
Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Estrogen receptor beta is coex ...... feration rate in breast cancer
@ast
Estrogen receptor beta is coex ...... feration rate in breast cancer
@en
type
label
Estrogen receptor beta is coex ...... feration rate in breast cancer
@ast
Estrogen receptor beta is coex ...... feration rate in breast cancer
@en
prefLabel
Estrogen receptor beta is coex ...... feration rate in breast cancer
@ast
Estrogen receptor beta is coex ...... feration rate in breast cancer
@en
P2093
P2860
P1476
Estrogen receptor beta is coex ...... feration rate in breast cancer
@en
P2093
M Pelto-Huikko
T A Järvinen
P2860
P356
10.1016/S0002-9440(10)64702-5
P407
P577
2000-01-01T00:00:00Z